Mid Atlantic Financial Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$6.33M Buy
147,216
+4,019
+3% +$178K 0.42% 44
2021
Q2
$5.61M Buy
143,197
+4,625
+3% +$180K 0.38% 56
2021
Q1
$5.02M Buy
138,572
+6,101
+5% +$217K 0.37% 59
2020
Q4
$4.88M Buy
132,471
+22,037
+20% +$808K 0.37% 62
2020
Q3
$4.11M Buy
110,434
+1,058
+1% +$37.1K 0.36% 63
2020
Q2
$3.39M Buy
109,376
+7,355
+7% +$250K 0.33% 69
2020
Q1
$3.16M Sell
102,021
-11,780
-10% -$401K 0.36% 59
2019
Q4
$4.23M Sell
113,801
-3,618
-3% -$129K 0.4% 54
2019
Q3
$4M Sell
117,419
-9,145
-7% -$333K 0.43% 49
2019
Q2
$5.2M Sell
126,564
-1,868
-1% -$74.2K 0.54% 28
2019
Q1
$5.17M Buy
128,432
+851
+0.7% +$34.1K 0.56% 25
2018
Q4
$5.28M Buy
+127,581
New +$5.3M 0.66% 29

Other funds holding PFE

Mid Atlantic Financial Management's PFE Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Pfizer (PFE) stake by 2.8% in Q3 2021, buying an estimated $178K and bringing the position to 147,216 shares worth $6.33M. The position accounts for 0.42% of the portfolio, ranked #44.

Mid Atlantic Financial Management first reported a position in PFE in Q4 2018 and has held it in 12 quarters since. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Mid Atlantic Financial Management held 147,216 shares of Pfizer worth $6.33M as of Q3 2021.
  • Mid Atlantic Financial Management bought 4,019 Pfizer shares in Q3 2021, an estimated $178K.
  • Pfizer made up 0.42% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #44 holding.
  • Mid Atlantic Financial Management first reported a position in Pfizer in Q4 2018 and has held it in 12 quarters since.
  • 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.